Anna Lorenzin1, Francesco Garzotto1, Alberta Alghisi2, Mauro Neri1, Dario Galeano1, Stefania Aresu3, Antonello Pani3, Enrico Vidal4, Zaccaroa Ricci5, Luisa Murer4, Stuart L Goldstein6, Claudio Ronco1,2,3,4,5,7. 1. International Renal Research Institute of Vicenza (IRRIV), Vicenza, Italy. 2. Department of Immunology and Blood Transfusions, San Bortolo Hospital, Vicenza, Italy. 3. Nephrology, Dialysis and Transplantation "G. Brotzu" Hospital, Cagliari, Italy. 4. Nephrology, Dialysis and Transplant Unit, Department of Woman's and Child's Health, Hospital and University of Padova, Padova, Italy. 5. Department of Cardiology and Cardiac Surgery, Pediatric Cardiac Intensive Care Unit, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy. 6. Center for Acute Care Nephrology, Cincinnati Children's Hospital, Cincinnati, OH, USA. stuart.goldstein@cchmc.org. 7. Department of Nephrology, Dialysis and Transplantation, San Bortolo Hospital, Vicenza, Italy.
Abstract
BACKGROUND: The CARdiorenal PEDIatric EMergency (CARPEDIEM) machine was originally designed to perform only continuous venovenous hemofiltration (CVVH) in neonatal and pediatric patients. In some cases, adequate convective clearance may not be reached because of a limited blood flow. In such conditions, the application of diffusive clearance [continuous venovenous hemodialysis (CVVHD)] would help optimize blood purification. In this study, the CARPEDIEM™ machine was modified to enable the circulation of dialysis through the filter allowing testing of the performance of CARPEDIEM™ machine in CVVHD. METHODS: Three different polyethersulfone hemodialyzers (surface area = 0.1 m(2), 0.2 m(2), and 0.35 m(2), respectively) were tested in vitro with a scheduled combination of plasma flow rates (Qp = 10-20-30 ml/min) and dialysis fluid flow rate (Qd = 5-10-15 ml/min). Three sessions were performed in co-current and one in counter-current configuration (as control) for each filter size. Clearance was measured from the blood and dialysate sides and results with mass balance error greater than 5 % were discarded. RESULTS: Urea and creatinine clearances for each plasma/dialysate combination are reported: clearance increase progressively for every filter proportionally to plasma flow rates. Similarly, clearances increase progressively with dialysate flow rates at a given plasma flow. The clearance curve tends to present a steep increase for small increases in plasma flow in the range below 10 ml/min, while the curve tends to plateau for values averaging 30 ml/min. As expected, the plateau is reached earlier with the smaller filter showing the effect of membrane surface-area limitation. At every plasma flow, the effect of dialysate flow increase is evident and well defined, showing that saturation of effluent was not achieved completely in any of the experimental conditions explored. No differences (p > 0.05 for all values) were obtained in experiments using whole blood instead of plasma or using co-current versus counter-current dialysate flow configuration. CONCLUSIONS: Although plasma flow and filter surface give an important contribution to the level of clearance urea and creatinine, it appears evident that dialysate flow plays an essential role in the blood purification process, justifying the use of CVVHD versus CVVH in case of high dialysis dose requirement and/or limited blood flow rate.
BACKGROUND: The CARdiorenal PEDIatric EMergency (CARPEDIEM) machine was originally designed to perform only continuous venovenous hemofiltration (CVVH) in neonatal and pediatric patients. In some cases, adequate convective clearance may not be reached because of a limited blood flow. In such conditions, the application of diffusive clearance [continuous venovenous hemodialysis (CVVHD)] would help optimize blood purification. In this study, the CARPEDIEM™ machine was modified to enable the circulation of dialysis through the filter allowing testing of the performance of CARPEDIEM™ machine in CVVHD. METHODS: Three different polyethersulfone hemodialyzers (surface area = 0.1 m(2), 0.2 m(2), and 0.35 m(2), respectively) were tested in vitro with a scheduled combination of plasma flow rates (Qp = 10-20-30 ml/min) and dialysis fluid flow rate (Qd = 5-10-15 ml/min). Three sessions were performed in co-current and one in counter-current configuration (as control) for each filter size. Clearance was measured from the blood and dialysate sides and results with mass balance error greater than 5 % were discarded. RESULTS:Urea and creatinine clearances for each plasma/dialysate combination are reported: clearance increase progressively for every filter proportionally to plasma flow rates. Similarly, clearances increase progressively with dialysate flow rates at a given plasma flow. The clearance curve tends to present a steep increase for small increases in plasma flow in the range below 10 ml/min, while the curve tends to plateau for values averaging 30 ml/min. As expected, the plateau is reached earlier with the smaller filter showing the effect of membrane surface-area limitation. At every plasma flow, the effect of dialysate flow increase is evident and well defined, showing that saturation of effluent was not achieved completely in any of the experimental conditions explored. No differences (p > 0.05 for all values) were obtained in experiments using whole blood instead of plasma or using co-current versus counter-current dialysate flow configuration. CONCLUSIONS: Although plasma flow and filter surface give an important contribution to the level of clearance urea and creatinine, it appears evident that dialysate flow plays an essential role in the blood purification process, justifying the use of CVVHD versus CVVH in case of high dialysis dose requirement and/or limited blood flow rate.
Authors: Young Bae Sohn; Kyung Hoon Paik; Hee Yeon Cho; Su Jin Kim; Sung Won Park; Eun Sun Kim; Yun Sil Chang; Won-Soon Park; Yoon-Ho Choi; Dong-Kyu Jin Journal: Korean J Pediatr Date: 2012-08-23
Authors: Jordan M Symons; Patrick D Brophy; Melissa J Gregory; Nancy McAfee; Michael J G Somers; Timothy E Bunchman; Stuart L Goldstein Journal: Am J Kidney Dis Date: 2003-05 Impact factor: 8.860
Authors: David J Askenazi; Stuart L Goldstein; Rajesh Koralkar; James Fortenberry; Michelle Baum; Richard Hackbarth; Doug Blowey; Timothy E Bunchman; Patrick D Brophy; Jordan Symons; Annabelle Chua; Francisco Flores; Michael J G Somers Journal: J Pediatr Date: 2012-10-24 Impact factor: 4.406
Authors: Matthew W Harer; David T Selewski; Kianoush Kashani; Rajit K Basu; Katja M Gist; Jennifer G Jetton; Scott M Sutherland; Michael Zappitelli; Stuart L Goldstein; Theresa Ann Mottes; David J Askenazi Journal: J Perinatol Date: 2020-09-05 Impact factor: 2.521
Authors: Carina E Imburgia; Joseph E Rower; Danielle J Green; Autumn M Mcknite; Walter E Kelley; Christopher A Reilly; Kevin M Watt Journal: ASAIO J Date: 2021-11-17 Impact factor: 3.826